Literature DB >> 31183750

Strength training and protein supplementation improve muscle mass, strength, and function in mobility-limited older adults: a randomized controlled trial.

Sigve Nyvik Aas1, Olivier Seynnes2, Haakon B Benestad3, Truls Raastad2.   

Abstract

BACKGROUND: Adaptation to strength training in very old mobility-limited individuals is not fully characterized. Therefore, the aim of this study was to perform a thorough investigation of the adaptation to a lower body strength training regime in this population, with particular emphasis on the relationship between changes in selected variables.
METHODS: Twenty-two mobility-limited older men and women (85 ± 6 years) were randomized to either a group performing 30 min of heavy-load strength training three times a week, with daily protein supplementation, for 10 weeks (ST), or a control group. End points were leg lean mass assessed by DXA, muscle thickness assessed by ultrasound, isometric and dynamic strength, rate of torque development, and functional capacity.
RESULTS: Leg lean mass increased from baseline in ST (0.7 ± 0.3 kg), along with increased thickness of vastus lateralis (4.4 ± 3.2%), rectus femoris (6.7 ± 5.1%), and vastus intermedius (5.8 ± 5.9%). The hypertrophy was accompanied by improved knee extensor strength (20-23%) and functional performance (7-11%). In ST, neither the change in leg lean mass nor muscle thickness correlated with changes in muscle strength. However, a strong correlation was observed between the change in isometric strength and gait velocity (r = 0.70).
CONCLUSIONS: The mismatch between gains in muscle size and strength suggests that muscle quality-related adaptations contributed to the increases in strength. The correlations observed between improvements in strength and function suggests that interventions eliciting large improvements in strength may also be superior in terms of functional gains in this population.

Entities:  

Keywords:  Frailty; Hypertrophy; Mobility limited; Resistance exercise; Sarcopenia; Skeletal muscle

Mesh:

Substances:

Year:  2019        PMID: 31183750     DOI: 10.1007/s40520-019-01234-2

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  5 in total

1.  The Effects of Graded Protein Intake in Conjunction with Progressive Resistance Training on Skeletal Muscle Outcomes in Older Adults: A Preliminary Trial.

Authors:  J Max Michel; Kristy K Lievense; Sam C Norton; Juliana V Costa; Kathryn H Alphin; Lydia A Bailey; Gary D Miller
Journal:  Nutrients       Date:  2022-06-30       Impact factor: 6.706

2.  Effectiveness of a resistance training program on physical function, muscle strength, and body composition in community-dwelling older adults receiving home care: a cluster-randomized controlled trial.

Authors:  Hilde Bremseth Bårdstu; Vidar Andersen; Marius Steiro Fimland; Lene Aasdahl; Truls Raastad; Kristoffer T Cumming; Atle Hole Sæterbakken
Journal:  Eur Rev Aging Phys Act       Date:  2020-08-07       Impact factor: 3.878

3.  Heterogeneity of the strength response to progressive resistance exercise training in older adults: Contributions of muscle contractility.

Authors:  Leatha A Clark; David W Russ; Dallin Tavoian; W David Arnold; Timothy D Law; Christopher R France; Brian C Clark
Journal:  Exp Gerontol       Date:  2021-06-04       Impact factor: 4.253

Review 4.  Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults.

Authors:  Everson A Nunes; Lauren Colenso-Semple; Sean R McKellar; Thomas Yau; Muhammad Usman Ali; Donna Fitzpatrick-Lewis; Diana Sherifali; Claire Gaudichon; Daniel Tomé; Philip J Atherton; Maria Camprubi Robles; Sandra Naranjo-Modad; Michelle Braun; Francesco Landi; Stuart M Phillips
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-20       Impact factor: 12.910

5.  Association between dietary protein intake and skeletal muscle mass in older Korean adults.

Authors:  Ha-Na Kim; Sang-Wook Song
Journal:  Eur Geriatr Med       Date:  2021-06-22       Impact factor: 1.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.